Abstract
Acetylcholine, glutamate, dopamine, serotonin (5-HT), gamma-aminobutyric acid, substance P (SP), amyloid-β (Aβ) and neurotrophic protein S100B are arguably the most important cognition-related biomarkers in the brain. Among this list are five neurotransmitters that signal through postsynaptic receptors. Our knowledge of cognition-related biomarkers has been advanced through translational experiments and clinical case-study data. Although these biomarkers are widespread in the brain and pronounced individual variations exist, these biomarkers can be used to identify both acute and chronic abnormalities following traumatic brain injury. Changes in these biomarkers likely indicate damage to brain networks or to key brain cell types that support cognitive functions. Identification of such biomarker abnormalities could result in earlier diagnoses, improved prognoses and therapies that enable neurotransmitters to return to normal levels.
Similar content being viewed by others
References
Anderson JJ, Chase TN, Engber TM (2011) Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats. Brain Res 623:189–194
Arciniegas DB (2011) Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 2: evidence from basic and clinical investigations. J Head Trauma Rehabil 26:319–323
Arciniegas DB, Silver JM (2006) Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol 17:25–42
Bales JW, Wagner AK, Kline AE, Dixon CE (2009) Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis. Neurosci Biobehav Rev 33:981–1003
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152
Beglinger LJ, Gaydos BL, Kareken DA, Tangphao-Daniels O, Siemers ER, Mohs RC (2004) Neuropsychological test performance in healthy volunteers before and after donepezil administration. J Psychopharmacol 18:102–108
Bogdanovitch UJ, Bazarevitch GJ, Kirillov AL (1975) The use of cholinesterase in severe head injury. Resuscitation 4:139–141
Celikyurt IK, Mutlu O, Ulak G, Akar FY, Erden FG (2011) Gabapentin: a GABA analogue, enhances cognitive performance in mice. Neurosci Lett 492:124–128
Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19:214–223
Chew E, Zafonte RD (2009) Pharmacological management of neurobehavioral disorders following traumatic brain injury—a state-of-the-art review. J Rehabil Res Dev 46:851–879
Cifariello A, Pompili A, Gasbarri A (2008) 5-HT receptors in the modulation of cognitive processes. Behav Brain Res 195:171–179
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923
Dardiotis E, Fountas KN, Dardioti M, Xiromerisiou G, Kapsalaki E, Tasiou A, Hadjigeorgiou GM (2010) Genetic association studies in patients with traumatic brain injury. Neurosurg Focus 28:E9
Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508:1–12
DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RS, Ikonomovic MD (2007) Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol 64:541–544
Dixon CE, Bao J, Bergmann JS, Johnson KM (1994a) Traumatic brain injury reduces hippocampal high-affinity [3H] choline uptake but not extracellular choline levels in rats. Neurosci Lett 180:127–130
Dixon CE, Hamm RJ, Taft WC, Hayes RL (1994b) Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat. J Neurotrauma 11:275–287
Dixon CE, Bao J, Johnson KM, Yang K, Whitson J, Clifton GL, Hayes RL (1995a) Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. Neurosci Lett 198:111–114
Dixon CE, Liu SJ, Jenkins LW, Bhattachargee M, Whitson JS, Yang K, Hayes RL (1995b) Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat. Behav Brain Res 70:125–131
Dixon CE, Bao J, Long DA, Hayes RL (1996) Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharmacol Biochem Behav 53:679–686
Donkin JJ, Nimmo AJ, Cernak I, Blumbergs PC, Vink R (2009) Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J Cereb Blood Flow Metab 29:1388–1398
Donkin JJ, Cernak I, Blumbergs PC, Vink R (2011) A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. J Neurotrauma 28:217–224
Faden AI, Demediuk P, Panter SS, Vink R (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798–800
Fernandes C, Hoyle E, Dempster E, Schalkwyk LC, Collier DA (2006) Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav 5:433–440
Floresco SB, Jentsch JD (2011) Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 36:227–250
Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C, Tse MT (2006) Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 31:297–309
Frank MJ, Fossella JA (2011) Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacology 36:133–152
Frank MJ, O’Reilly RC (2006) A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120:497–517
Gauchy C, Desban M, Glowinski J, Kemel ML (1996) Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9] substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum. Neuroscience 73:929–939
Gibson CJ, Meyer RC, Hamm RJ (2010) Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus. J Biomed Sci 17:38
Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT (1996) Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer’s disease. Ann Neurol 39:62–70
Graham DI, Gentleman SM, Lynch A, Roberts GW (1995) Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 21:27–34
Harvey JA (1996) Serotonergic regulation of associative learning. Behav Brain Res 73:47–50
Heizmann CW, Fritz G, Schäfer BW (2002) S100 proteins:structure, functions and pathology. Front Biosci 7:d1356–d1368
Hornstein A, Lennihan L, Seliger G, Lichtman S, Schroeder K (1996) Amphetamine in recovery from brain injury. Brain Inj 10:145–148
Horsburgh K, Fitzpatrick M, Nilsen M, Nicoll JA (1997) Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat. Brain Res 763:103–110
Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533–554
Huston JP, Hasenöhrl RU (1995) The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 66:117–127
Johansson IM, Birzniece V, Lindblad C, Olsson T, Bäckström T (2002) Allopregnanolone inhibits learning in the Morris water maze. Brain Res 934:125–131
Kandimalla RJ, Wani WY, Anand R, Kaushal A, Prabhakar S, Grover VK, Bharadwaj N, Jain K, Gill KD (2013) Apolipoprotein e levels in the cerebrospinal fluid of north Indian patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen 28:258–262
Karaküçük EI, Paşaoğlu H, Paşaoğlu A, Oktem S (1997) Endogenous neuropeptides in patients with acute traumatic head injury II: changes in the levels of cerebrospinal fluid substance P, serotonin and lipid peroxidation products in patients with head trauma. Neuropeptides 31:259–263
Kay AD, Petzold A, Kerr M, Keir G, Thompson E, Nicoll JA (2003a) Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. J Neurotrauma 20:943–952
Kay AD, Petzold A, Kerr M, Keir G, Thompson EJ, Nicoll JA (2003b) Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury. J Neurotrauma 20:243–250
Kleindienst A, Ross Bullock M (2006) A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 23:1185–1200
Kline AE, Yan HQ, Bao J, Marion DW, Dixon CE (2000) Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci Lett 280:163–166
Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269:1737–1740
Kraus MF, Maki P (1997) The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury. Brain Inj 11:455–460
Leonard JR, Maris DO, Grady MS (1994) Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat. J Neurotrauma 11:379–392
Lin RC (1995) Reactive astrocytes express substance-P immunoreactivity in the adult forebrain after injury. NeuroReport 7:310–312
Luo P, Fei F, Zhang L, Qu Y, Fei Z (2011) The role of glutamate receptors in traumatic brain injury: implications for postsynaptic density in pathophysiology. Brain Res Bull 85:313–320
Magnoni S, Brody DL (2010) New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch Neurol 67:1068–1073
Mahesh R, Pandey DK, Katiyar S, Kukade G, Viyogi S, Rudra A (2010) Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats. Indian J Exp Biol 48:466–473
Marklund N, Blennow K, Zetterberg H, Ronne-Engström E, Enblad P, Hillered L (2009) Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J Neurosurg 110:1227–1237
Massucci JL, Kline AE, Ma X, Zafonte RD, Dixon CE (2004) Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci Lett 372:127–131
McAllister TW (2011) Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci 13:287–300
Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130:1007S–1015S
Mello e Souza T, Rohden A, Meinhardt M, Gonçalves CA, Quillfeldt JA (2000) S100B infusion into the rat hippocampus facilitates memory for the inhibitory avoidance task but not for the open-field habituation. Physiol Behav 71:29–33
Mohler H, Fritschy JM, Lüscher B, Rudolph U, Benson J, Benke D (1996) The GABAA receptors. From subunits to diverse functions. Ion Channels 4:89–113
Mtchedlishvili Z, Lepsveridze E, Xu H, Kharlamov EA, Lu B, Kelly KM (2010) Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury. Neurobiol Dis 38:464–475
NIH Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury (1999) Rehabilitation of persons with traumatic brain injury. JAMA 282:974–983
Niogi SN, Mukherjee P, Ghajar J, Johnson C, Kolster RA, Sarkar R, Lee H, Meeker M, Zimmerman RD, Manley GT, McCandliss BD (2008) Extent of microstructural white matter injury in postconcussive syndrome correlates with impaired cognitive reaction time: a 3T diffusion tensor imaging study of mild traumatic brain injury. AJNR Am J Neuroradiol 29:967–973
Nortje J, Menon DK (2004) Traumatic brain injury: physiology, mechanisms, and outcome. Curr Opin Neurol 17:711–718
O’Dowd BS, Zhao WQ, Ng KT, Robinson SR (1997) Chicks injected with antisera to either S-100 alpha or S-100 beta protein develop amnesia for a passive avoidance task. Neurobiol Learn Mem 67:197–206
Olsen AS, Sozda CN, Cheng JP, Hoffman AN, Kline AE (2012) Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT-receptor agonist buspirone. J Neurotrauma 29:1898–1907
Pappius HM (1989) Involvement of indoleamines in functional disturbances after brain injury. Prog Neuropsychopharmacol Biol Psychiatry 13:353–361
Parker D, Zhang W, Grillner S (1998) Substance P modulates NMDA responses and causes long-term protein synthesis-dependent modulation of the lamprey locomotor network. J Neurosci 18:4800–4813
Phillips JP, Devier DJ, Feeney DM (2003) Rehabilitation pharmacology: bridging laboratory work to clinical application. J Head Trauma Rehabil 18:342–356
Pocivavsek A, Icenogle L, Levin ED (2006) Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. Psychopharmacology 188:597–604
Raabe A, Seifert V (2000) Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results. Neurosurg Rev 23:136–138
Ray S, Howells C, Eaton ED, Butler CW, Shabala L, Adlard PA, West AK, Bennett WR, Guillemin GJ, Chung RS (2011) Tg2576 cortical neurons that express human Ab are susceptible to extracellular Aβ-induced, K+ efflux dependent neurodegeneration. PLoS One 6:e19026
Roberts GW, Gentleman SM, Lynch A, Graham DI (1991) beta A4 amyloid protein deposition in brain after head trauma. Lancet 338:1422–1423
Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu Rev Med 47:387–400
Rowley NM, Madsen KK, Schousboe A, Steve WH (2012) Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int 61:546–558
Sawyer E, Mauro LS, Ohlinger MJ (2008) Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 42:247–252
Schallert T, Hernandez TD, Barth TM (1986) Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 379:104–111
Scremin OU, Li MG, Roch M, Booth R, Jenden DJ (2006) Acetylcholine and choline dynamics provide early and late markers of traumatic brain injury. Brain Res 1124:155–166
Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1–58
Shen KZ, North RA (1992) Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons. Neuroscience 50:345–353
Sivanandam TM, Thakur MK (2012) Traumatic brain injury: a risk factor for Alzheimer’s disease. Neurosci Biobehav Rev 36:1376–1381
Souza DG, Mendonça VA, de A Castro MS, Poole S, Teixeira MM (2002) Role of tachykinin NK receptors on the local and remote injuries following ischaemia and reperfusion of the superior mesenteric artery in the rat. Br J Pharmacol 11:303–312
Stelzer A, Shi H (1994) Impairment of GABAA receptor function by N-methyl-D-aspartate-mediated calcium influx in isolated CA1 pyramidal cells. Neuroscience 62:813–828
Tenovuo O (2005) Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. Prog Neuropsychopharmacol Biol Psychiatry 29:61–67
Türkmen S, Löfgren M, Birzniece V, Bäckström T, Johansson IM (2006) Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 139:651–659
van Holstein M, Aarts E, van der Schaaf ME, Geurts DE, Verkes RJ, Franke B, van Schouwenburg MR, Cools R (2011) Human cognitive flexibility depends on dopamine D2 receptor signaling. Psychopharmacology 218:567–578
Vink R, Nimmo AJ (2002) Novel therapies in development for the treatment of traumatic brain injury. Expert Opin Investig Drugs 11:1375–1386
Vink R, Donkin JJ, Cruz MI, Nimmo AJ, Cernak I (2004) A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. J Am Coll Nutr 23:538S–540S
Visser AK, van Waarde A, Willemsen AT, Bosker FJ, Luiten PG, den Boer JA, Kema IP, Dierckx RA (2011) Measuring serotonin synthesis: from conventional methods to PET tracers and their clinical implications. Eur J Nucl Med Mol Imaging 38:576–591
Wagner AK, Sokoloski JE, Ren D, Chen X, Khan AS, Zafonte RD, Michael AC, Dixon CE (2005) Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem 95:457–465
Wagner AK, Sokoloski JE, Chen X, Harun R, Clossin DP, Khan AS, Andes-Koback M, Michael AC, Dixon CE (2009) Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission. J Neurochem 110:801–810
Wakade C, Sukumari-Ramesh S, Laird MD, Dhandapani KM, Vender JR (2010) Delayed reduction in hippocampal postsynaptic density protein-95 expression temporally correlates with cognitive dysfunction following controlled cortical impact in mice. J Neurosurg 113:1195–1201
Winocur G, Roder J, Lobaugh N (2001) Learning and memory in S100-beta transgenic mice: an analysis of impaired and preserved function. Neurobiol Learn Mem 75:230–243
Zainaghi IA, Forlenza OV, Gattaz WF (2007) Abnormal APP processing in platelets of patients with Alzheimer’s disease: correlations with membrane fluidity and cognitive decline. Psychopharmacology 192:547–553
Zhou F, Hongmin B, Xiang Z, Enyu L (2003) Changes of mGluR4 and the effects of its specific agonist L-AP4 in a rodent model of diffuse brain injury. J Clin Neurosci 10:684–688
Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA (2008) Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 25:279–290
Zlotnik A, Sinelnikov I, Gruenbaum BF, Gruenbaum SE, Dubilet M, Dubilet E, Leibowitz A, Ohayon S, Regev A, Boyko M, Shapira Y, Teichberg VI (2012) Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology 116:73–83
Acknowledgments
This study was supported by grants from the Shanghai Committee of Science and Technology (No. 114119a8300), Shanghai Health Bureau (No. 2010167) and BaoShan Scientific and Technological Development Fund (11-E-1).
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, ZL., Feng, DF. Biomarkers of cognitive dysfunction in traumatic brain injury. J Neural Transm 121, 79–90 (2014). https://doi.org/10.1007/s00702-013-1078-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-013-1078-x